Clinical Trials Logo

Clinical Trial Summary

In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.


Clinical Trial Description

After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02566291
Study type Observational
Source Johannes Gutenberg University Mainz
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date March 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05573919 - VivAer: A Correlation Between Symptom Scores and Objective Findings N/A
Recruiting NCT03842839 - Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography N/A
Completed NCT04765761 - Proseal Laryngeal Mask Airway With or Without Introducer-tool Stabilization for Pressure Controlled Ventilation N/A
Recruiting NCT06288516 - BenRalizumab Effect on Airway Remodeling in Severe asTHma Phase 4
Enrolling by invitation NCT05692362 - Measure Airway Compliance by Endobronchial Optical Coherence Tomography
Completed NCT01178229 - Physiotherapy on the Airway of Bruxist Children Phase 1/Phase 2
Completed NCT06236971 - Effect of Lateral Positions on the Shape of Upper Airway
Terminated NCT01505933 - Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine Phase 2
Recruiting NCT05550402 - Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) N/A